$NCTY

The9 LTD

No enriched coverage for $NCTY in the last 7 days.

No SEC Form 4 filings for $NCTY in the last 30 days.

See all $NCTY insider activity →
Med

The9 (NCTY) Q2 2026 Earnings Call Transcript

The9 Limited (NCTY) reported Q2 2026 net income of $32 million, up 39% sequentially, driven by digital assets. The company holds $120 million in cryptocurrency, including 347 BTC and 1.9 billion 9BIT tokens. The9bit platform has 8 million users and 180,000 games created. The9 expects revenue growth in H2 2026 from in-game purchases and is focusing on AI-powered gaming and digital asset integration. The company also expects a 15-16% stake in Nanyang Biologics Pte. Ltd. post-merger.

NCTY sentiment & insider activity

Recent NCTY coverage spans earnings, financial news and mergers & acquisitions.

What's driving NCTY

AlphAI scores every news story that mentions NCTY with an AI model for sentiment and relevance, and aggregates insider trades from The9 LTD's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $NCTY

Score
$NCTYMed

The9 (NCTY) Q2 2026 Earnings Call Transcript

The9 Limited (NCTY) reported Q2 2026 net income of $32 million, up 39% sequentially, driven by digital assets. The company holds $120 million in cryptocurrency, including 347 BTC and 1.9 billion 9BIT tokens. The9bit platform has 8 million users and 180,000 games created. The9 expects revenue growth in H2 2026 from in-game purchases and is focusing on AI-powered gaming and digital asset integration. The company also expects a 15-16% stake in Nanyang Biologics Pte. Ltd. post-merger.

$NCTYMed

The9 LTD (NCTY): Financial results for Q2 2026

The9 LTD (NCTY) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 The9 Reports US$32 Million Net Income for Second Quarter of 2026, Up Over 39% Sequentially Increase driven by the fair-value recognition of 9BIT tokens received under the Company’s cooperation agreement with the 9BIT Foundation as the9bit continued to expand AI capab

The9 Investee Nanyang Biologics (NYB) Advancing Planned Nasdaq Listing for the US$1.5 Billion Business Combination

The9 Limited (Nasdaq: NCTY) said its investee Nanyang Biologics (NYB) received SEC effectiveness notice for its Form F-4 tied to a planned Nasdaq listing under ticker NYB. The business combination values NYB at about US$1.5 billion. The9 expects its subsidiary Gamenow to own 15% to 16% post-closing, subject to an Aug. 19, 2026 vote and Nasdaq approval.

$NCTYMed

The9 Reports Record Quarterly Profit as Digital Asset Income Drives Strongest Quarter Since IPO

The9 (NASDAQ:NCTY) reported record Q1 2026 net income of $23 million, driven mainly by digital asset-related income from receiving about 1.425 billion 9BIT tokens, valued using quoted market prices. The company also received 475 million more 9BIT tokens in April. It said the9bit surpassed 8 million registered users and 110,000 user-created games, and crypto holdings were valued around $110 million.

The9 Names George Lai Chief Executive Officer

The9 Limited (Nasdaq: NCTY) appointed George Lai as CEO effective July 27, 2026. He previously served as CFO since 2008. Founder and Chairman Jun Zhu becomes Executive Chairman. Interim CFO duties will be handled by Wei Ji. The company cited the9bit progress: 8 million users and 110,000+ games in under a year.

Related tickers